cardiac fibrosis
Showing 1 - 8 of 8
Metabolic Syndrome, Cardiac Fibrosis Trial in L'Aquila (Inositol and alpha-lactalbumin)
Recruiting
- Metabolic Syndrome
- Cardiac Fibrosis
- Inositol and alpha-lactalbumin
-
L'Aquila, ItalyUOC Medicina Interna e Nefrologia P.O. AQ
Jan 18, 2023
Immune Correlates of Cardiac Structure and Function
Completed
- Perinatal HIV Infection
- +2 more
- Cardiac MRI
-
Durham, North CarolinaDuke University Health System
Oct 24, 2022
Plasminogen Activator Inhibitor-1 Deficiency, Cardiac Fibrosis Trial (Metformin Extended Release Oral Tablet)
Not yet recruiting
- Plasminogen Activator Inhibitor-1 Deficiency
- Cardiac Fibrosis
- Metformin Extended Release Oral Tablet
- (no location specified)
Aug 1, 2022
Pilot Study of Cardiac MR in Patients With Muscular Dystrophy
Recruiting
- Muscular Dystrophies
- +3 more
-
Washington, District of ColumbiaChildren's National Health System
Mar 1, 2022
Cardiovascular Fibrosis in Idiopathic Pulmonary Fibrosis
Recruiting
- Idiopathic Pulmonary Fibrosis
- +2 more
-
Monza, MB, ItalyOspedale San Gerardo Monza - Università Milano Bicocca
Sep 28, 2021
Myocardial Deterioration asPreventive, Disease Staging, and
Unknown status
- Cardiomyopathies
- +4 more
-
Stanford, CaliforniaStanford University
Apr 25, 2018
Circulating P3NP and Cardiovascular Events in Hemodialysis
Completed
- Cardiovascular Events
- Cardiac Fibrosis
-
Kyoto, JapanToujinkai Hospital
Jan 4, 2018
Cardiac Fibrosis, Diastolic Dysfunction Trial in Tucson (Pycnogenol, Placebo)
Terminated
- Cardiac Fibrosis
- Diastolic Dysfunction
- Pycnogenol
- Placebo
-
Tucson, ArizonaUniversity of Arizona, Sarver Heart Center
Dec 14, 2013